Hepatitis C Virus Infection in Patients With Hemoglobinopathies
Treatment of Hepatitis C Virus Infection With Direct-acting Antiviral Drugs in Patients With Hemoglobinopathies
Sponsor: Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello
This observational or N/A phase trial investigates Hemoglobinopathies and Hepatitis C, Chronic and is currently completed. Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 2 earlier versions
-
Sep 2017 — Apr 2018 [monthly]
Completed NA
-
Jun 2017 — Sep 2017 [monthly]
Completed NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello
- Cardarelli Hospital
- Ente Ospedaliero Ospedali Galliera
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Reggio Calabria
- Società Italiana Talassemie ed Emoglobinopatie
- University of Cagliari
- University of Campania Luigi Vanvitelli
- University of Palermo
- University of Turin, Italy
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.